;. Chrebp?, ). Mlx, and J. W. , Jonker (pcDNA3.1/Hnf4?), H. Towle (minimal promoter PGL3/ChREBP luciferase reporter), and J. Chiang (human and mouse PGL3/ Cyp8b1 promoter luciferase reporters). We thank A. Herling and D. Schmoll (Sanofi) for providing S4048 and L. Chan for sharing the ChREBP ChIPseq data set

P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels, Role of bile acids and bile acid receptors in metabolic regulation, Physiol Rev, vol.89, pp.147-191, 2009.

R. A. Haeusler, B. Astiarraga, S. Camastra, D. Accili, and E. Ferrannini, Human insulin resistance is associated with increased plasma levels of 12?-hydroxylated bile acids, Diabetes, vol.62, pp.4184-4191, 2013.

L. J. Bennion and S. M. Grundy, Effects of diabetes mellitus on cholesterol metabolism in man, N Engl J Med, vol.296, pp.1365-1371, 1977.

R. A. Haeusler, M. Pratt-hyatt, C. L. Welch, C. D. Klaassen, and D. Accili, Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia, Cell Metab, vol.15, pp.65-74, 2012.

G. Brufau, F. Stellaard, K. Prado, V. W. Bloks, E. Jonkers et al., Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism, Hepatology, vol.52, pp.1455-1464, 2010.

J. Chiang, Bile acids: regulation of synthesis, J Lipid Res, vol.50, pp.1955-1966, 2009.

C. Gälman, B. Angelin, and M. Rudling, Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis, Gastroenterology, vol.129, pp.1445-1453, 2005.

T. Li, X. Kong, E. Owsley, E. Ellis, S. Strom et al., Insulin regulation of cholesterol 7?-hydroxylase expression in human hepatocytes, J Biol Chem, vol.281, pp.28745-28754, 2006.

T. Li, D. Chanda, Y. Zhang, H. S. Choi, and J. Chiang, Glucose stimulates cholesterol 7alpha-hydroxylase gene transcription in human hepatocytes, J Lipid Res, vol.51, pp.832-842, 2010.

H. Ishida, C. Yamashita, Y. Kuruta, Y. Yoshida, and M. Noshiro, Insulin is a dominant suppressor of sterol 12?-hydroxylase P450 (CYP8B) expression in rat liver: possible role of insulin in circadian rhythm of CYP8B, J Biochem, vol.127, pp.57-64, 2000.

R. Bandsma, A. Grefhorst, T. H. Van-dijk, F. H. Van-der-sluijs, A. Hammer et al., Enhanced glucose cycling and suppressed de novo synthesis of glucose-6-phosphate result in a net unchanged hepatic glucose output in ob/ob mice, Diabetologia, vol.47, pp.2022-2031, 2004.

M. H. Oosterveer and K. Schoonjans, Hepatic glucose sensing and integrative pathways in the liver, Cell Mol Life Sci, vol.71, pp.1453-1467, 2014.

J. Y. Chou and B. C. Mansfield, Mutations in the glucose-6-phosphatasealpha (G6PC) gene that cause type Ia glycogen storage disease, Hum Mutat, vol.29, pp.921-930, 2008.

E. Mutel, A. Abdul-wahed, N. Ramamonjisoa, A. Stefanutti, I. Houberdon et al., Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas, J Hepatol, vol.54, pp.529-537, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00575314

R. A. Haeusler, K. H. Kaestner, and D. Accili, FoxOs function synergistically to promote glucose production, J Biol Chem, vol.285, pp.35245-5248, 2010.

W. T. Hermens, O. Ter-brake, P. A. Dijkhuizen, M. A. Sonnemans, D. Grimm et al., Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system, Hum Gene Ther, vol.10, pp.1885-1891, 1999.

C. H. Samanez, S. Caron, O. Briand, H. Dehondt, I. Duplan et al., The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism, Arch Physiol Biochem, vol.118, pp.102-111, 2012.

X. Tong, F. Zhao, A. Mancuso, J. J. Gruber, and C. B. Thompson, The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation, Proc Natl Acad Sci U S A, vol.106, pp.21660-21665, 2009.

J. Folch, M. Lees, and G. H. Sloane, A simple method for the isolation and purification of total lipids from animal tissues, J Biol Chem, vol.266, pp.497-509, 1957.

H. U. Bergmeyer, Methods of enzymatic analysis, vol.1974, pp.1089-1204

J. F. De-boer, M. Schonewille, M. Boesjes, H. Wolters, V. W. Bloks et al., Intestinal farnesoid X receptor controls transintestinal cholesterol excretion in mice, Gastroenterology, vol.152, pp.1126-1138, 2017.

D. M. Heuman, Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions, J Lipid Res, vol.30, pp.719-730, 1989.

R. Duggavathi, D. H. Volle, C. Mataki, M. C. Antal, N. Messaddeq et al., Liver receptor homolog 1 is essential for ovulation, Genes Dev, vol.22, pp.1871-1876, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00311099

M. Schreurs, M. H. Oosterveer, V. A. Cortés, R. Havinga, and A. W. Herling, Carbohydrate-response-element-binding protein (ChREBP) and not the liver X receptor ? (LXR?) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1, Biochem J, vol.432, pp.249-254, 2010.

. Kok-t, C. V. Hulzebos, H. Wolters, R. Havinga, L. B. Agellon et al., Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein, J Biol Chem, vol.278, pp.41930-41937, 2003.

C. Gälman, I. Arvidsson, B. Angelin, and M. Rudling, Monitoring hepatic cholesterol 7alpha-hydroxylase activity by assay of the stable bile acid intermediate 7alpha-hydroxy-4-cholesten-3-one in peripheral blood, J Lipid Res, vol.44, pp.859-866, 2003.

A. Abdul-wahed, A. Gautier-stein, S. Casteras, M. Soty, D. Roussel et al., A link between hepatic glucose production and peripheral energy metabolism via hepatokines, Mol Metab, vol.3, pp.531-543, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-01350728

N. Poungvarin, B. Chang, M. Imamura, J. Chen, K. Moolsuwan et al., Genome-wide analysis of ChREBP binding sites on male mouse liver and white adipose chromatin, Endocrinology, vol.156, pp.1982-1994, 2015.

Y. Inoue, A. M. Yu, S. H. Yim, X. Ma, K. W. Krausz et al., Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4alpha, J Lipid Res, vol.47, pp.215-227, 2006.

B. L. O'callaghan, S. H. Koo, Y. Wu, H. C. Freake, and H. C. Towle, Glucose regulation of the acetyl-CoA carboxylase promoter PI in rat hepatocytes, J Biol Chem, vol.276, pp.16033-16039, 2001.

J. Hasegawa, K. Osatomi, R. F. Wu, and K. Uyeda, A novel factor binding to the glucose response elements of liver pyruvate kinase and fatty acid synthase genes, J Biol Chem, vol.274, pp.1100-1107, 1999.

A. Yamada, K. Honma, K. Mochizuki, and T. Goda, BRD4 regulates fructose-inducible lipid accumulation-related genes in the mouse liver, Metabolism, vol.65, pp.1478-1488, 2016.

W. Ke, . Hatzivassiliou-g, U. M. Sachdeva, T. V. Bui, J. R. Cross et al., ATP-citrate lyase links cellular metabolism to histone acetylation, Science, vol.324, pp.1076-1080, 2009.

E. Bertaggia, K. K. Jensen, J. Castro-perez, Y. Xu, D. Paolo et al., Cyp8b1 ablation prevents Western diet-induced weight gain and hepatic steatosis because of impaired fat absorption, Am J Physiol Endocrinol Metab, vol.313, pp.121-133, 2017.

D. Q. Wang, S. Tazuma, D. E. Cohen, and M. C. Carey, Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse, Am J Physiol Gastrointest Liver Physiol, vol.285, pp.494-502, 2003.

Y. Bonde, G. Eggertsen, and M. Rudling, Mice abundant in muricholic bile acids show resistance to dietary induced steatosis, weight gain, and to impaired glucose metabolism, PLoS One, vol.11, p.147772, 2016.

W. M. Pandak, P. Bohdan, C. Franklund, D. H. Mallonee, G. Eggertsen et al., Expression of sterol 12?-hydroxylase alters bile acid pool composition in primary rat hepatocytes and in vivo, Gastroenterology, vol.120, pp.1801-1809, 2001.

F. Stellaard, V. Bergmann, K. Sudhop, T. Lütjohann, and D. , The value of surrogate markers to monitor cholesterol absorption, synthesis and bioconversion to bile acids under lipid lowering therapies, J Steroid Biochem Mol Biol, vol.169, pp.111-122, 2017.

T. Li, J. M. Francl, S. Boehme, A. Ochoa, Y. Zhang et al., Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity, J Biol Chem, vol.287, pp.1861-1873, 2012.

W. M. Van-waarde, H. J. Verkade, H. Wolters, R. Havinga, J. Baller et al., Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats, Gastroenterology, vol.122, pp.1842-1852, 2002.

H. Herrema, M. Meissner, T. H. Van-dijk, G. Brufau, R. Boverhof et al., Bile salt sequestration induces hepatic de novo lipogenesis through farnesoid X receptor-and liver X receptor?-controlled metabolic pathways in mice, Hepatology, vol.51, pp.806-816, 2010.

L. Ma, L. N. Robinson, and H. C. Towle, ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver, J Biol Chem, vol.281, pp.28721-28730, 2006.

R. Chevre, D. Castaño, T. Chua, M. Corlia, and J. V. Patankar, Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice, FASEB J, vol.32, pp.3792-3802, 2018.

. Werner-a, D. M. Minich, R. Havinga, V. Bloks, H. Van-goor et al., Fat malabsorption in essential fatty aciddeficient mice is not due to impaired bile formation, Am J Physiol Gastrointest Liver Physiol, vol.283, pp.900-908, 2002.

S. Takahashi, T. Fukami, Y. Masuo, C. N. Brocker, C. Xie et al., Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans, J Lipid Res, vol.57, pp.2130-2137, 2016.

R. Dentin, F. Benhamed, I. Hainault, V. R. Fauveau, F. Foufelle et al., Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice, Diabetes, vol.55, pp.2159-2170, 2006.

R. Kursawe, S. Caprio, C. Giannini, D. Narayan, A. Lin et al., Decreased transcription of ChREBP-?/? isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia, Diabetes, vol.62, pp.837-844, 2013.

L. Eissing, T. Scherer, K. Tödter, U. Knippschild, J. W. Greve et al., De novo lipogenesis in human fat and liver is linked to ChREBP-? and metabolic health, Nat Commun, vol.4, p.1528, 2013.

, Author names in bold designate shared co-first authorship. Supporting Information Additional Supporting Information may be found at onlinelibrary